1. Home
  2. MSBI vs DCTH Comparison

MSBI vs DCTH Comparison

Compare MSBI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

N/A

Current Price

$32.29

Market Cap

684.0M

Sector

Finance

ML Signal

N/A

DCTH

Delcath Systems Inc.

N/A

Current Price

$19.97

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSBI
DCTH
Founded
1881
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
684.0M
578.4M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
MSBI
DCTH
Price
$32.29
$19.97
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
★ $34.75
$24.00
AVG Volume (30 Days)
131.4K
★ 302.4K
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 4.16%
N/A
EPS Growth
N/A
★ 107.53
EPS
★ 2.51
0.04
Revenue
N/A
N/A
Revenue This Year
$3.01
$24.61
Revenue Next Year
$1.58
$24.27
P/E Ratio
★ $12.62
$374.00
Revenue Growth
N/A
N/A
52 Week Low
$15.06
$8.12
52 Week High
$35.10
$17.42

Technical Indicators

Market Signals
Indicator
MSBI
DCTH
Relative Strength Index (RSI) 45.55 78.56
Support Level $31.73 $14.14
Resistance Level $34.65 N/A
Average True Range (ATR) 1.16 0.68
MACD -0.14 0.41
Stochastic Oscillator 29.84 99.02

Price Performance

Historical Comparison
MSBI
DCTH

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: